Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pustulosis Palmaris et Plantaris”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03988335
What this trial is testing

Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Aristea Therapeutics, Inc. 35
Early research (Phase 1)Study completedNCT03972280
What this trial is testing

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

Who this might be right for
Hidradenitis SuppurativaPalmoplantar Pustulosis
CSL Behring 39
Large-scale testing (Phase 3)Study completedNCT04061252
What this trial is testing

KHK4827 in Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Kyowa Kirin Co., Ltd. 126
Not applicableNot Yet RecruitingNCT06790940
What this trial is testing

Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information

Who this might be right for
Psoriasis (PsO)Psoriatic ArthritisPalmoplantar Pustulosis (PPP)+1 more
Shanghai Yueyang Integrated Medicine Hospital 310
Testing effectiveness (Phase 2)Study completedNCT03135548
What this trial is testing

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Who this might be right for
Psoriasis
Boehringer Ingelheim 59
Testing effectiveness (Phase 2)Ended earlyNCT01197989
What this trial is testing

Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis

Who this might be right for
Pustulosis of Palms and Soles
Lenzi Egisto S.P.A. 17
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Testing effectiveness (Phase 2)Study completedNCT01845987
What this trial is testing

The Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Janssen Pharmaceutical K.K. 49
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Testing effectiveness (Phase 2)Study completedNCT03633396
What this trial is testing

Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Vanda Pharmaceuticals 59
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Testing effectiveness (Phase 2)Study completedNCT04572997
What this trial is testing

Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)

Who this might be right for
Palmoplantar Pustulosis
Kristian Reich 21
Not applicableLooking for participantsNCT07270003
What this trial is testing

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Xijing Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04057937
What this trial is testing

Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Amgen 90